Within this review, viral-only cohorts (e.g., influenza-related ARF) and mixed-aetiology CAP cohorts both demonstrated higher SP-D with increasing severity, supporting SP-D as a pathogen-agnostic marker of epithelial barrier injury. The gene discussed is SFTPD; the disease is influenza.